David PS
Member
Hibiscus tea is known to lower blood pressure. Here is a deep link into the relevant section of Ray Peat's email exchange where he mentions hibiscus tea.
Ray Peat Email Exchanges - Ray Peat Forum Wiki
There are lots of reports of people getting good results from 2-3 cups of tea per day. I do not drink tea but I add hibiscus to the water when I am making white rice. Here is product that I use. https://www.amazon.com/Frontier-Org...erByKeyword=blood+pressure#reviews-filter-bar
Hibiscus tea contains Gossypetin
Ray Peat Email Exchanges - Ray Peat Forum Wiki
Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies
The effectiveness of Hibiscus sabdariffa L. (HS) in the treatment of risk factors associated with cardiovascular disease is assessed in this review by taking a comprehensive approach to interpreting the randomized clinical trial (RCT) results in the context ...
www.ncbi.nlm.nih.gov
There are lots of reports of people getting good results from 2-3 cups of tea per day. I do not drink tea but I add hibiscus to the water when I am making white rice. Here is product that I use. https://www.amazon.com/Frontier-Org...erByKeyword=blood+pressure#reviews-filter-bar
Hibiscus tea contains Gossypetin
Gossypetin - Wikipedia
en.wikipedia.org
In this mouse study, Gossypetin showed protective effects in 5xFAD mice model AD by enhancing microglial Aβ phagocytosis.Gossypetin, also known as 3,5,7,8,3',4'-hexahydroxyflavone, is a flavonol, a type of flavonoid. It has been isolated from the flowers and the calyx of Hibiscus sabdariffa (roselle) and exhibits a strong antibacterial activity.[1][2] The compound has also been found to act as an antagonist of TrkB.[3] Recently it was shown that gossypetin has radioprotective activity.
Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ - PubMed
Gossypetin showed protective effects against AD by enhancing microglial Aβ phagocytosis. Gossypetin appears to be a novel promising therapeutic candidate against AD.
pubmed.ncbi.nlm.nih.gov
Last edited: